<aside> 💡 　I would like to introduce atDose Co., Ltd. (headquartered in Kanagawa, founded in 2017, hereinafter referred to as 'the Company'), a notable entity within the healthcare innovation sector. From my perspective as a seasoned business executive, the Company's clear focus on revolutionizing drug delivery through its core technology, the Electro-Osmotic Pump (EO pump), is particularly commendable. Their vision to establish a new paradigm for drug administration, centered on ultra-small and continuous local delivery, demonstrates significant potential.

The Company's technology is particularly compelling due to its unique ability to precisely control the delivery of even highly viscous substances, such as silicone oil, in minute quantities, especially when used with thin needles. This capability offers substantial advantages in minimally invasive treatments, such as Micro-Incision Vitrectomy Surgery (MIVS) in ophthalmology, where precision is paramount.

Beyond ophthalmology, the Company's platform exhibits several key strengths. Researchers benefit from the ability to administer drugs with precision in vivo and in vitro, with adjustable timing, quantity, and speed. Their customizable dosing devices further enhance their appeal within the research sector. This inherent precision and control translate to significant marketability across various sectors. While current research focuses on local administration in ophthalmology and anticancer agents, the potential extends to numerous other applications. Furthermore, the Company's proactive approach in seeking collaborations with medical device manufacturers positions them for scalable future product releases.

In essence, the company is not merely developing an electroosmotic flow pump embedded with a feedback sensor suitable for IoMT (Internet of Medical Things), but also envisioning a versatile platform for future targeted therapeutics. They are actively pursuing partnerships to realize this promising potential. I extend my sincere wishes for the Company's continued success in contributing to improved quality of life.

Return to English Top

</aside>